Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Smolen

Showing results (21-30 of 863) with videos related to

Pageof 87
Sort By:
Current Opinion in Rheumatology|March 31, 2016
Treat-to-target as an approach in inflammatory arthritisJosef S Smolen
Zeitschrift Fur Rheumatologie|April 13, 1999
[To the Christian-Georg-Schmorl-memorial lecture: 50 years of lupus erythemotosus cells]J S Smolen
Arthritis Research|July 12, 2002
Therapy of systemic lupus erythematosus: a look into the futureJosef S Smolen
Nature Reviews. Rheumatology|May 1, 2010
Pharmacotherapy: How well can we compare different biologic agents for RA?Josef S Smolen
Annals of the Rheumatic Diseases|January 3, 2024
Greetings from the editor 2024Josef S Smolen
Rheumatology (Oxford, England)|January 11, 2025
Poor prognostic factors and unmet needs in rheumatoid arthritisJosef S Smolen
Annals of the Rheumatic Diseases|May 12, 2018
Greetings from the editorJosef S Smolen
Annals of the Rheumatic Diseases|May 22, 2020
Greetings from the editorJosef S Smolen
Nature Reviews. Disease Primers|April 25, 2020
Rheumatoid arthritis Primer - behind the scenesJosef S Smolen
British Journal of Rheumatology|April 1, 1992
The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)J S Smolen
Pageof 87

Showing results (21-30 of 863) with videos related to

Sort By:
Pageof 87
Current Opinion in Rheumatology|March 31, 2016
Treat-to-target as an approach in inflammatory arthritisJosef S Smolen
Zeitschrift Fur Rheumatologie|April 13, 1999
[To the Christian-Georg-Schmorl-memorial lecture: 50 years of lupus erythemotosus cells]J S Smolen
Arthritis Research|July 12, 2002
Therapy of systemic lupus erythematosus: a look into the futureJosef S Smolen
Nature Reviews. Rheumatology|May 1, 2010
Pharmacotherapy: How well can we compare different biologic agents for RA?Josef S Smolen
Annals of the Rheumatic Diseases|January 3, 2024
Greetings from the editor 2024Josef S Smolen
Rheumatology (Oxford, England)|January 11, 2025
Poor prognostic factors and unmet needs in rheumatoid arthritisJosef S Smolen
Annals of the Rheumatic Diseases|May 12, 2018
Greetings from the editorJosef S Smolen
Annals of the Rheumatic Diseases|May 22, 2020
Greetings from the editorJosef S Smolen
Nature Reviews. Disease Primers|April 25, 2020
Rheumatoid arthritis Primer - behind the scenesJosef S Smolen
British Journal of Rheumatology|April 1, 1992
The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)J S Smolen
Pageof 87